D Collen

Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans.

M Verstraete, H Bounameaux, F De Cock et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 155 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Tissue-Type Plasminogen Activator

D Collen, H.R. Lijnen · Haemostasis · 2009 · 78 citations

Measurement of Urokinase-Type Plasminogen Activator (u-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies

Veerle Darras, M Thienpont, DC Stump et al. · Thrombosis and Haemostasis · 1986 · 71 citations

Life Sciences, Internal Medicine, Clinical Immunology +13

Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.

Mario Colucci, José A. Páramo, D Collen · PubMed · 1986 · 59 citations

Life Sciences, Pharmacology, Signal Transduction +5

Absence of Synergism Between Tissue-Type Plasminogen Activator (t-PA), Single-Chain UrokinaseType Plasminogen Activator (scu-PA) and Urokinase on Clot Lysis in a Plasma Milieu In Vitro

D Collen, F De Cock, E Demarsin et al. · Thrombosis and Haemostasis · 1986 · 52 citations

Medicine, Pharmacology, Biochemical Pharmacology +15